UM  > Institute of Chinese Medical Sciences
Affiliated with RCfalse
Synthesis and pharmacological validation of fluorescent diarylsulfonylurea analogues as NLRP3 inhibitors and imaging probes
Zhao, Jiannan1,2,4,5; Li, Yongling2,3; Ma, Jing2; Liu, Jingting2; Xiao, Ruoxuan2; Wang, Linlin8; Li, Peng7; He, Yinyan6; Qian, Feng2; Zhang, Ao1,2,4,5; Sun, Zhen Liang3; Ding, Chunyong2
Source PublicationEuropean Journal of Medicinal Chemistry

The NOD-like receptor family pyrin domain-containing protein 3 (NLRP3) is a key cytosolic pattern recognition receptor that senses diverse pathogen- and host-originated threat signals. Aberrant activation of NLRP3 inflammasomes is closely associated with the pathogenesis of various complex inflammatory diseases. Nevertheless, the detailed regulation mechanism of NLRP3 inflammasome and its pathogenic roles in the inflammation progression remain to be fully elucidated. Fluorescent imaging with small molecule probe can provide valuable visualization information on the expression, occupancy and bio-distribution of target protein. Herein, we reported a series of diarylsulfonylurea NLRP3 fluorescent inhibitors bearing an amino benzodiazole fluorophore. Compared to the previously reported NLRP3 fluorescent probes, these inhibitors are more structurally concise and membrane permeable due to no additionally appended fluorophore via a linker. Among this series, compound 13a exhibited the most potent cellular NLRP3 inhibitory effect with an IC value of 49 nM, and significantly suppressed LPS/Nigericin-induced secretion of active caspase-1 and mature IL-1β in a dose-dependent manner to block the activation of NLRP3 inflammasome. Meanwhile, this new probe exhibited promising fluorescent properties for specifically detecting and imaging the LPS-induced or constitutively expressed NLRP3 proteins in RAW264.7 cells. Collectively, probe 13a is a potent NLRP3 fluorescent inhibitor with cellular NLRP3 imaging ability, which is useful for NLRP3 inhibitor screening and related mechanism study.

KeywordFluorescence Imaging Inflammasome Inhibitor Nlrp3 Sulfonylurea
URLView the original
Indexed BySCIE
WOS Research AreaPharmacology & Pharmacy
WOS SubjectChemistry, Medicinal
WOS IDWOS:000793638500008
Scopus ID2-s2.0-85128198698
Fulltext Access
Citation statistics
Cited Times [WOS]:1   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Corresponding AuthorSun, Zhen Liang; Ding, Chunyong
Affiliation1.School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China
2.Pharm-X Center, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai, 200240, China
3.Affiliated Fengxian Hospital, School of Pharmaceutical Science, Southern Medical University, Shanghai, 201499, China
4.Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, 201203, China
5.University of Chinese Academy of Sciences, Beijing, 100049, China
6.Department of Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, 201204, China
7.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China
8.School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China
Recommended Citation
GB/T 7714
Zhao, Jiannan,Li, Yongling,Ma, Jing,et al. Synthesis and pharmacological validation of fluorescent diarylsulfonylurea analogues as NLRP3 inhibitors and imaging probes[J]. European Journal of Medicinal Chemistry,2022,237.
APA Zhao, Jiannan,Li, Yongling,Ma, Jing,Liu, Jingting,Xiao, Ruoxuan,Wang, Linlin,Li, Peng,He, Yinyan,Qian, Feng,Zhang, Ao,Sun, Zhen Liang,&Ding, Chunyong.(2022).Synthesis and pharmacological validation of fluorescent diarylsulfonylurea analogues as NLRP3 inhibitors and imaging probes.European Journal of Medicinal Chemistry,237.
MLA Zhao, Jiannan,et al."Synthesis and pharmacological validation of fluorescent diarylsulfonylurea analogues as NLRP3 inhibitors and imaging probes".European Journal of Medicinal Chemistry 237(2022).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zhao, Jiannan]'s Articles
[Li, Yongling]'s Articles
[Ma, Jing]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zhao, Jiannan]'s Articles
[Li, Yongling]'s Articles
[Ma, Jing]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zhao, Jiannan]'s Articles
[Li, Yongling]'s Articles
[Ma, Jing]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.